4//SEC Filing
MURDOCK TERRY L 4
Accession 0001562180-23-005816
CIK 0001560241other
Filed
Jul 6, 8:00 PM ET
Accepted
Jul 7, 4:08 PM ET
Size
9.3 KB
Accession
0001562180-23-005816
Insider Transaction Report
Form 4
MURDOCK TERRY L
SVP of Development Operations
Transactions
- Sale
Common Stock
2023-07-05$2.45/sh−1,361$3,339→ 70,078 total
Footnotes (3)
- [F1]The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sales were to satisfy tax withholding obligations to be funded by a "sell-to-cover" transaction and do not represent discretionary transactions by the Reporting Person. Such sales were automatic and intended to qualify under Rule 10b5-1.
- [F2]The price represents the weighted average price with a low of $2.4250 and a high of $2.4704. The Reporting Person undertakes to provide G1 Therapeutics, Inc., any security holder of G1 Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]Represents (i) 5,553 shares of common stock; (ii) 4,125 RSUs from award granted on January 4, 2021; (iii) 7,500 RSUs from award granted on January 3, 2022; (iv) 17,900 RSUs from award granted on January 3, 2023, and (v) 35,000 RSUs from award granted on May 10, 2023.
Issuer
G1 Therapeutics, Inc.
CIK 0001560241
Entity typeother
Related Parties
1- filerCIK 0001274071
Filing Metadata
- Form type
- 4
- Filed
- Jul 6, 8:00 PM ET
- Accepted
- Jul 7, 4:08 PM ET
- Size
- 9.3 KB